Showing results (1291-1300 of 3,153) with videos related to

Sort By:
Pageof 316
Neuro-Oncology|June 15, 2016
Clinical parameters outweigh diffusion- and perfusion-derived MRI parameters in predicting survival in newly diagnosed glioblastomaSina Burth, Philipp Kickingereder, Oliver Eidel, et al.
Neuro-Oncology|May 8, 2016
Diagnostic value of glutamate with 2-hydroxyglutarate in magnetic resonance spectroscopy for IDH1 mutant gliomaHiroaki Nagashima, Kazuhiro Tanaka, Takashi Sasayama, et al.
Neuro-Oncology|November 10, 2017
Exercise ameliorates neurocognitive impairments in a translational model of pediatric radiotherapyIman Sahnoune, Taeko Inoue, Shelli R Kesler, et al.
Neuro-Oncology|November 30, 2017
Germline SUFU mutation carriers and medulloblastoma: clinical characteristics, cancer risk, and prognosisLéa Guerrini-Rousseau, Christelle Dufour, Pascale Varlet, et al.
Neuro-Oncology|October 20, 2017
Outcome of patients with intracranial non-germinomatous germ cell tumors-lessons from the SIOP-CNS-GCT-96 trialGabriele Calaminus, Didier Frappaz, Rolf Dieter Kortmann, et al.
Neuro-Oncology|June 30, 2016
Multimodal MRI features predict isocitrate dehydrogenase genotype in high-grade gliomasBiqi Zhang, Ken Chang, Shakti Ramkissoon, et al.
Neuro-Oncology|November 29, 2020
Alpha 1-antichymotrypsin contributes to stem cell characteristics and enhances tumorigenicity of glioblastomaMontserrat Lara-Velazquez, Natanael Zarco, Anna Carrano, et al.
Neuro-Oncology|November 29, 2020
The genetic landscape of choroid plexus tumors in children and adultsChristian Thomas, Patrick Soschinski, Melissa Zwaig, et al.
Neuro-Oncology|November 30, 2020
What is the Burden of Proof for Tumor Mutational Burden in gliomas?Mustafa Khasraw, Kyle M Walsh, Amy B Heimberger, et al.
Neuro-Oncology|June 20, 2022
FRK inhibits glioblastoma progression via phosphorylating YAP and inducing its ubiquitylation and degradation by Siah1Yan Wang, Kai Wang, Jiale Fu, et al.
Pageof 316